Could a 3-Day test be enough for bladder device success?

NCT ID NCT06226220

Recruiting now Symptom relief Sponsor: University of Chicago Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a 3-day trial of a nerve-stimulating device for bladder control works as well as the standard 7-day trial. About 193 women with urgent or frequent urination will be randomly assigned to either a 3-day or 7-day test. The goal is to see if the shorter trial leads to similar rates of getting the permanent implant.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: sacral neuromodulation (electrical stimulation device)
What this could lead to: If successful, this could make the testing phase for a bladder control device shorter and more convenient, potentially leading to faster treatment.
What could go wrong: This is an early-stage study comparing two trial lengths, not testing a new treatment. The shorter trial may not predict long-term success as well as the longer one.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVERACTIVE BLADDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

overactive bladder urethral syndrome Urinary Incontinence Urinary Incontinence, Urge

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OVERACTIVE BLADDER URGE INCONTINENCE URGENCY-FREQUENCY SYNDROME

Contacts and locations

Locations

University of Chicago
RECRUITING

Chicago, Illinois, 60637, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.